{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:14:34Z","timestamp":1770070474854,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.cbi.2010.03.015","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T04:33:25Z","timestamp":1268714005000},"page":"81-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism"],"prefix":"10.1016","volume":"185","author":[{"given":"Kavita","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen Kumar","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Spec No. 2","key":"10.1016\/j.cbi.2010.03.015_bib1","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease","volume":"16","author":"Thomas","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2010.03.015_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1742-4658.2008.06297.x","article-title":"Parkinson's disease: recent progress","volume":"275","author":"Galter","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2010.03.015_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.281.4.341","article-title":"Parkinson disease in twins: an etiologic study","volume":"281","author":"Tanner","year":"1999","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.cbi.2010.03.015_bib4","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/S1353-8020(08)70022-1","article-title":"Gene-environment interactions in Parkinson's disease","volume":"13","author":"Ross","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.53.3.566","article-title":"Parkinson's disease in twins: a follow-up study","volume":"53","author":"Vieregge","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.03.015_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1212\/01.WNL.0000129841.30587.9D","article-title":"No evidence for heritability of Parkinson disease in Swedish twins","volume":"63","author":"Wirdefeldt","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.03.015_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-008-0350-x","article-title":"Animal models of Parkinson's disease progression","volume":"115","author":"Meredith","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cbi.2010.03.015_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1742-4658.2008.06302.x","article-title":"Parkinson's disease: genetic versus toxin-induced rodent models","volume":"275","author":"Terzioglu","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2010.03.015_bib9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.03.015_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.cbi.2010.03.015_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: insights into parkinsonian neurodegeneration","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"issue":"Suppl. 2","key":"10.1016\/j.cbi.2010.03.015_bib12","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib13","first-page":"3","article-title":"Two wrong makes a right: nicotine and caffeine as defensive agents against Parkinson's disease","volume":"8","author":"Ho","year":"2002","journal-title":"Nutr. Bytes"},{"key":"10.1016\/j.cbi.2010.03.015_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bcp.2009.05.003","article-title":"Multiple roles for nicotine in Parkinson's disease","volume":"78","author":"Quik","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2010.03.015_bib15","first-page":"538","article-title":"Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation","volume":"57","author":"Xie","year":"2007","journal-title":"Comp. Med."},{"key":"10.1016\/j.cbi.2010.03.015_bib16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.20029","article-title":"Smoking and Parkinson's disease: systematic review of prospective studies","volume":"19","author":"Allam","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cbi.2010.03.015_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2008.02.023","article-title":"Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse","volume":"1207","author":"Singh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2008.02.011","article-title":"Smoking and tea consumption delay onset of Parkinson's disease","volume":"15","author":"Kandinov","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.21782","article-title":"Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk","volume":"23","author":"Powers","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib21","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.21706","article-title":"Coffee and tea consumption and the risk of Parkinson's disease","volume":"22","author":"Hu","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cbi.2010.03.015_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pneurobio.2008.03.003","article-title":"Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents","volume":"85","author":"Ward","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.cbi.2010.03.015_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2010.03.015_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2006.05.003","article-title":"Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease","volume":"248","author":"Kalda","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"11 Suppl. 6","key":"10.1016\/j.cbi.2010.03.015_bib25","first-page":"S10","article-title":"Exciting news about A2A receptors","volume":"61","author":"Svenningsson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2010.03.015_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nurx.2006.05.008","article-title":"Microarrays in Parkinson's disease: a systematic approach","volume":"3","author":"Miller","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.cbi.2010.03.015_bib27","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.cbi.2010.03.015_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0165-6147(03)00067-1","article-title":"Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs","volume":"24","author":"Mandel","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2010.03.015_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.neuro.2007.02.013","article-title":"Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study","volume":"28","author":"Wang","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2010.03.015_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10048-006-0033-5","article-title":"Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease","volume":"7","author":"Duke","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.cbi.2010.03.015_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molbrainres.2004.03.025","article-title":"Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways","volume":"126","author":"Bonin","year":"2004","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib32","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.neuroscience.2008.06.064","article-title":"Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum","volume":"155","author":"Pattarini","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbi.2010.03.015_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12033-008-9060-9","article-title":"Gene expression profiles of mouse striatum in control and maneb+paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts","volume":"40","author":"Patel","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.cbi.2010.03.015_bib34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/pr070546l","article-title":"Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease","volume":"7","author":"Chin","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuint.2007.02.003","article-title":"Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease","volume":"50","author":"Anantharam","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cbi.2010.03.015_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1152\/physiolgenomics.90353.2008","article-title":"Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling","volume":"37","author":"Yu","year":"2009","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.cbi.2010.03.015_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.2009.06373.x","article-title":"Gene regulation of alpha4beta2 nicotinic receptors: microarray analysis of nicotine-induced receptor up-regulation and anti-inflammatory effects","volume":"111","author":"Hosur","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.03.015_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2009.06.002","article-title":"Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine treated mouse striatum","volume":"1283","author":"Singh","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/rej.2009.0850","article-title":"The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in MPTP-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection","volume":"12","author":"Singh","year":"2009","journal-title":"Rejuvenat. Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng0502-19","article-title":"GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways","volume":"31","author":"Dahlquist","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2010.03.015_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.intimp.2009.03.003","article-title":"Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease","volume":"9","author":"Kurkowska-Jastrzebska","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cbi.2010.03.015_bib42","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1471-4159.2008.05310.x","article-title":"MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation\u2014relevance in a mouse model of Parkinson's disease","volume":"105","author":"Thomas","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.03.015_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1124\/mol.107.038158","article-title":"Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1","volume":"72","author":"Hamill","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2010.03.015_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.03.015_bib45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nbd.2003.09.001","article-title":"ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia","volume":"14","author":"Galter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cbi.2010.03.015_bib46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1096\/fasebj.10.7.8635688","article-title":"Antioxidant and redox regulation of gene transcription","volume":"10","author":"Sen","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2010.03.015_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.febslet.2004.03.070","article-title":"Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain","volume":"567","author":"Dzwonek","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2010.03.015_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-4159.2008.05399.x","article-title":"A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells","volume":"106","author":"Choi","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2010.03.015_bib49","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.0611671104","article-title":"The pRb\/E2F cell-cycle pathway mediates cell death in Parkinson's disease","volume":"104","author":"Hoglinger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl. 2","key":"10.1016\/j.cbi.2010.03.015_bib50","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.cdd.4401777","article-title":"Another way to die: autophagic programmed cell death","volume":"12","author":"Tsujimoto","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2010.03.015_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-4-20","article-title":"Calcium signaling in neurodegeneration","volume":"4","author":"Marambaud","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cbi.2010.03.015_bib52","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1023\/A:1022597010078","article-title":"Stress, aging, and brain oxidative damage","volume":"24","author":"Liu","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2010.03.015_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/mol.108.046888","article-title":"Caffeine stimulates cytochrome oxidase expression and activity in the striatum in a sexually dimorphic manner","volume":"74","author":"Jones","year":"2008","journal-title":"Mol. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:20:57Z","timestamp":1757856057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0009279710001547"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.03.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}